DOTMA 是一种阳离子脂类，被用作基因治疗的非病毒载体。DOTMA 作为脂质体的成分用于封装 siRNA、microRNA 和寡核苷酸，并用于体外基因转染。DOTMA 通过诱导脂质体上的正电荷，促进脂质体与细胞膜的有效相互作用。DOTMA 在体外和体内均表现出良好的基因转染效果。

Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.

Paquinimod 是一种 S100A9 抑制剂，可防止 S100A9 与 TLR-4 结合。